Back to discover
Disease

Diabetic Foot

Late-stage therapeutic developmentEmerging researchRising momentum
5
Publications
24
Clinical trials
2
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

Research2012-06-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical Milestones13View all 13
+5 more in the activity timeline below
Activity timeline13

Therapeutic landscape

Therapies with a regulatory footing for this condition, alongside the wider set of agents co-studied with it in the literature.

Approved & established therapies

Approval — Treatment Ertapenem SUN is indicated in paediatric patients (3 months to 17 years of age)… (2022)

Tigecyclineapproved

Approval — Tygecycline Accord is indicated in adults and in children from the age of eight years for… (2020)

Besilesomabapproved

Approval — This medicinal product is for diagnostic use only and the approved indication is scintigr… (2010)

Clinical trials

15 sponsors · 2 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
24
All trials
6
Active
18
Late-stage
6
Completed
Late-stage studies
Recently completed

Regulatory timeline

Drug regulatory events matched to this condition by indication — EMA.

First approvals
2022emaApprovalErtapenem sodium· Treatment Ertapenem SUN is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4.4 and 5.1): Intra-abdominal infections Community acquired pneumonia Acute gynaecological infections Diabetic foot infections of the skin and soft tissue (see section 4.4) Prevention Ertapenem SUN is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4.4). Consideration should be given to official guidance on the appropriate use of antibacterial agents. source ↗
2020emaApprovalTigecycline· Tygecycline Accord is indicated in adults and in children from the age of eight years for the treatment of the following infections (see sections 4.4 and 5.1): Complicated skin and soft tissue infections (cSSTI), excluding diabetic foot infections (see section 4.4) Complicated intra-abdominal infections (cIAI) Tygecycline Accord should be used only in situations where other alternative antibiotics are not suitable (see sections 4.4, 4.8 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents. source ↗
2010emaApprovalBesilesomab· This medicinal product is for diagnostic use only and the approved indication is scintigraphic imaging, in conjunction with other appropriate imaging modalities, for determining the location of inflammation/infection in peripheral bone in adults with suspected osteomyelitis. Scintimun should not be used for the diagnosis of diabetic foot infection. source ↗
2006emaApprovalTigecycline· Tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: Complicated skin and soft tissue infections (cSSTI), excluding diabetic foot infections Complicated intra-abdominal infections (cIAI) Tygacil should be used only in situations where other alternative antibiotics are not suitable. Consideration should be given to official guidance on the appropriate use of antibacterial agents. appropriate use of antibacterial agents. source ↗
2002emaApprovalErtapenem sodium· Treatment Treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required: intra-abdominal infections; community-acquired pneumonia; acute gynaecological infections; diabetic foot infections of the skin and soft tissue. Prevention Invanz is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery. Consideration should be given to official guidance on the appropriate use of antibacterial agents. source ↗

European Medicines Agency (CC BY 4.0). Events are matched to this condition by drug indication text — approvals/updates for drugs indicated for it, not disease-specific acts.

Research activity

5 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20122024
Most influential
Recent publications
Major themes5
  • Diabetic Foot2
  • Cardiovascular Diseases1
  • Diabetes Mellitus1
  • Diabetes Mellitus, Type 21
  • Platelet-Rich Plasma1
Leading journals5
  • Circulation1
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1
  • Diabetes care1
  • Diabetes/metabolism research and reviews1
  • International wound journal1
Leading researchers8
  • Armstrong DG2
  • Embil JM2
  • Lipsky BA2
  • Abbas ZG1
  • Aragón-Sánchez J1
  • Berendt AR1
  • Conte MS1
  • Cornia PB1
Affiliations (unnormalised)6
  • University of Washington2
  • Abbas Medical Centre1
  • Alberta Public Laboratories1
  • Green Templeton College1
  • Gustave Dron Hospital1
  • Infection and Immunity Institute1

Related conditions

2 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Diabetic foot refers to common foot problems in people with diabetes mellitus. It arises from a combination of diabetic neuropathy, peripheral vascular disease, and infection, and can progress from injury or infection to severe ulceration, gangrene, and surgical amputation.

Causes

The grounding supports a multifactorial aetiology rather than a single cause. Diabetic foot problems are caused by combinations of diabetic neuropathies, peripheral vascular diseases, and infection, with many diabetic foot infections beginning in a wound, often a neuropathic ulceration.

Pathophysiology

Loss of sensation and poor circulation are central to the disease process. These changes allow injuries to go unnoticed and impair healing, so wounds can become colonized and then infected, with progression to deeper ulceration, gangrene, and possible amputation.

Risk factors

Diabetes mellitus is the underlying condition associated with risk. The supplied material also supports neuropathic ulceration, poor circulation/peripheral vascular disease, and existing wounds as factors that predispose to infection and severe foot complications.

Current standard of care

Management is described at the level of wound and infection care, vascular assessment, and prevention-oriented foot care. For diabetic foot infections, care is guided by infection severity classification and vascular assessment, with escalation to hospitalization, imaging, surgical intervention, or amputation when needed; multidisciplinary diabetic wound and amputation prevention clinics are also emphasized.

AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION, SURGICAL.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.